FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

21033711000001102: Losartan 25mg tablets (Bristol Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Aug 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70335601000001113 Losartan 25mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70335701000001115 Losartan 25mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Losartan 25mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely losartan potassium 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) Has active ingredient Losartan potassium false Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Losartan potassium true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Losartan 25mg tablets (Bristol Laboratories Ltd) 28 tablet Has AMP True Losartan 25mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) 56 tablet Has AMP True Losartan 25mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Bristol Laboratories Ltd) 84 tablet Has AMP True Losartan 25mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start